VVM Pharma Invest SRL
VVM Pharma Invest reported total assets of €1.66m at the end of the 2026 financial year (annual accounts filed with the NBB on 08 Oct 2026).
The score of VVM Pharma Invest shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity +73 % Total assets -1 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
VVM Pharma Invest's annual accounts
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net result | 209,582 € | ||||
| Equity | 745,240 € | ||||
| Cash | 47,256 € | ||||
| EBITDA | 176,898 € | ||||
| Total assets | €1.66m |
Filed annual accounts
- Year ended 31 Mar 2026filed on 08 Oct 2026
- Year ended 31 Mar 2025filed on 24 Sep 2025
- Year ended 31 Mar 2024filed on 23 Oct 2024
- Year ended 31 Mar 2023filed on 03 Oct 2023
- Year ended 31 Mar 2022filed on 27 Sep 2022
VVM Pharma Invest's financial analysis
- Solvency44.9%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of VVM Pharma Invest
VVM Pharma Invest's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0536.716.836
- VAT number
- BE0536716836
- Peppol
- Registered · 0208:0536716836 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Jul 2013
- Registered office
- 8790 Waregem
- Latest accounts
- 2026 · filed on 08 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
VVM Pharma Invest (SRL) has been based in Waregem since 2013, active in: retail sale of pharmaceutical products. For 2026, it reports a net profit of 209,582 € and equity of 745,240 €; its revenue is not published. Its solvency stands at 44.9%, above the median of its sector (44.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to VVM Pharma Invest
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Gevaert Retail sale of pharmaceutical products Waregem · balance sheet €1.77m
- Pharmacie de Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- JD Farma Retail sale of pharmaceutical products Zedelgem · balance sheet €1.67m
- Cassart Pharma Retail sale of pharmaceutical products Silly · balance sheet €1.68m
- Youken Company Retail sale of pharmaceutical products Frameries · balance sheet €1.64m
- Sibilia Retail sale of pharmaceutical products Grimbergen · balance sheet €1.62m
- Gofran Retail sale of pharmaceutical products Zonhoven · balance sheet €1.71m
- Apoteek Jespers - Cuijpers Retail sale of pharmaceutical products Anderlecht · balance sheet €1.72m
Frequently asked questions about VVM Pharma Invest
What is the revenue of VVM Pharma Invest?
VVM Pharma Invest files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of VVM Pharma Invest?
In Belgium, the VAT number is the company number prefixed with BE: BE0536716836 for VVM Pharma Invest, if the company is VAT-registered. Its company number (CBE) is 0536.716.836.
Where is the registered office of VVM Pharma Invest?
According to the CBE register, the registered office of VVM Pharma Invest is in 8790 Waregem.
What is the equity of VVM Pharma Invest?
At the close of the 2026 financial year, the equity of VVM Pharma Invest amounts to 745,240 €, a solvency of 44.9% of total assets.
Who manages VVM Pharma Invest?
The register lists 4 active mandates at VVM Pharma Invest. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of VVM Pharma Invest
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →